找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Bispecific Antibodies; Roland E. Kontermann Book 2011 Springer-Verlag Berlin Heidelberg 2011 Cancer therapy.Hybridoma.Immunoglobulin.Immun

[復(fù)制鏈接]
樓主: invigorating
31#
發(fā)表于 2025-3-27 00:02:20 | 只看該作者
32#
發(fā)表于 2025-3-27 02:50:30 | 只看該作者
Die Technik der kystoskopischen Untersuchungble two different monospecific binding units into one molecule, two-in-one antibodies are dual-specific antibodies that can be produced as conventional IgG, in which each of the two identical Fab arms recognizes two distinct antigen epitopes. The first proof-of-concept two-in-one bH1 has been select
33#
發(fā)表于 2025-3-27 08:53:32 | 只看該作者
Pathologie der Harnleitermündung existing repertoires of such agents as produced by genetic engineering alone, we envisioned and developed the Dock-and-Lock (DNL) method, which enables site-specific conjugation of two modular components only with each other, producing a covalent construct of defined composition with retained bioac
34#
發(fā)表于 2025-3-27 13:24:07 | 只看該作者
Pathologie der Harnleitermündungherapy. For redirecting cytotoxic effector cells against tumors, typically the first binding site of a bispecific antibody recognizes a tumor-associated antigen, whereas the second site engages a stimulatory trigger molecule on effector cells. The adequate choice of the trigger molecule offers the o
35#
發(fā)表于 2025-3-27 14:55:39 | 只看該作者
Technik des Harnleiterkatheterismusrty enables the development of therapeutic strategies that are not possible with conventional monoclonal antibodies (mAbs). Advances in antibody engineering and the expanding knowledge of antigen profiling on malignant cells have provided innovative solutions for the development of various formats o
36#
發(fā)表于 2025-3-27 20:30:01 | 只看該作者
37#
發(fā)表于 2025-3-28 00:04:38 | 只看該作者
38#
發(fā)表于 2025-3-28 03:19:44 | 只看該作者
39#
發(fā)表于 2025-3-28 09:13:15 | 只看該作者
Technik des Harnleiterkatheterismuss are being pursued, including long-term gene correction of monogenetic diseases, eradication of tumor cells in cancer patients, or genetic vaccination for infectious diseases. Bispecific antibodies and gene therapy are connected in two ways. First, bispecific antibodies are tools of interest for th
40#
發(fā)表于 2025-3-28 12:24:17 | 只看該作者
Die Technik der kystoskopischen Untersuchungity to simultaneously bind to a specific antigen and a given detection moiety enables them to function as excellent bifunctional immunoprobes in diagnostic assays. BsMAb are being exploited for the development of simple, rapid, and highly sensitive immunoassays for diagnosis of bacterial and viral i
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 09:08
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
都兰县| 财经| 保康县| 长垣县| 察雅县| 宁蒗| 米泉市| 遂宁市| 龙泉市| 永吉县| 涿州市| 察哈| 梁山县| 榕江县| 伊金霍洛旗| 福清市| 平安县| 鞍山市| 茌平县| 西乡县| 司法| 辽阳市| 博野县| 海南省| 亚东县| 调兵山市| 柞水县| 平湖市| 南乐县| 万源市| 乌恰县| 威宁| 康乐县| 滦南县| 鄄城县| 松溪县| 休宁县| 建平县| 海原县| 德令哈市| 石泉县|